CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2, Double-Blind, Placebo-Controlled Study to Determine the Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects With External Genital Warts
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03981822
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:06.461051+00:00
- Published At
- 2021-09-22T00:00:00+00:00
- Record Updated At
- 2024-11-27
- Results Posted At
- 2021-09-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Condylomata Acuminata", "Papillomavirus Infections", "Skin Diseases, Viral", "Skin Diseases, Infectious", "Skin Diseases", "Sexually Transmitted Diseases, Viral", "Sexually Transmitted Diseases", "Warts"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-11-27"- protocolSection.identificationModule.nctId
"NCT03981822"- protocolSection.identificationModule.officialTitle
"A Phase 2, Double-Blind, Placebo-Controlled Study to Determine the Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects With External Genital Warts"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-09-22"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.